Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetylcholine biosynthesis refers to the cellular process by which the neurotransmitter acetylcholine (ACh) is produced. The two immediate precursors for acetylcholine synthesis are choline and acetyl coenzyme A (acetyl-CoA). The reaction is catalyzed by choline acetyltransferase (ChAT) in the cytoplasm of nerve terminals. The rate-limiting step is typically the availability of choline. After synthesis, ACh is transported into synaptic vesicles for storage until release upon neuronal stimulation. Once released into the synaptic cleft, ACh acts on its receptors (nicotinic or muscarinic) before being rapidly hydrolyzed by acetylcholinesterase into acetate and choline. The liberated choline is then reabsorbed for reuse in further rounds of synthesis. While not directly targeted, its modulation is crucial for cholinergic neurotransmission, impacting cognitive function and neuromuscular activity.
Not directly targeted by drugs; drugs modulate precursor availability or acetylcholine degradation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetylcholine Biosynthesis (ACh Biosynthesis).